NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/08/2025
Back to search
Official data from USPTO
AVANTI POLAR LIPIDS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
08/01/2025
Trademark type
Combined
Nice classes
1, 5, 40, 42
Filing date
09/26/2019
Registration date
07/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/08/2025
Last transaction
08/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2001
First use in commerce
05/01/2001
Drawing code
3
Owner type
16
Owner location
ALABASTER, AL
Examiner
PERKINS, ELLEN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "AVANTI" in a stylized font above the words "POLAR LIPIDS, INC." also in stylized font. The wording appears to the right of the design of a stylized liposome.
Holders and representatives
Holders
AVANTI POLAR LIPIDS, LLC
Avanti Polar Lipids, Inc.
Representatives
Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical compounds for scientific or research use; adjuvants for scientific or research use; chemical reagents for the delivery of lipids for scientific or research use; chemical compounds for use as standards for use with analytical techniquesmass spectrometry; compounds for scientific or research uselipidssynthetic lipidspolymer modified lipidslipids with modified head groupslipids with modified acyl chainsbioactive lipidsfluorescent lipidsisotope labeled lipidsoxidized lipidssphingolipidslipid extracts from natural sourceslipids conjugated with modified gold particles; compounds for scientific or research usefatty acidsglycerolipidsglycerophospholipidssphingolipidssaccharolipidssterol lipidsprenol lipidslipid preparations suitable for protein crystallizationlipid preparations suitable for protein solubilizationdetergentsamphiphilic detergentsantibodies; diagnostic reagents and analytical reagents for scientific or research use; formulations comprising lipids for scientific or research use; enzymes for scientific or research use; lipidschemical additivesexcipients for use in the manufacture of pharmaceutical preparations
Class 5
Adjuvants for medical use; immunostimulatory compoundslipids for medical use; medical diagnostic reagents; test strips for the detection of bacterial infections for medical use; isotopes for medical use
Class 40
cGMP custom manufacture of active agentsadditivesexcipients for others; cGMP custom manufacture of lipids for others; custom manufacturing services for others in the field of active agentsadditivesexcipients in pharmaceutical preparations; custom manufacturing services for others in the field of lipids; providing information relating to the custom manufacture of lipids and chemical compounds for scientific and medical research purposes
Class 42
Analytical servicesperforming nutraceutical testingNMR analysismass spectrometry analysisinfrared spectroscopy analysischromatography analysisgas chromatography analysisparticle size analysiszeta potential analysisthin layer chromatography analysiswater content analysisperoxide oxidation and phosphorous content analysischemical stability testingdevelopment of chemical analytical methods; scientific research and medical research services; analytical servicesperforming nutraceutical testingNMR analysismass spectrometry analysisinfrared spectroscopy analysischromatography analysisgas chromatography analysisparticle size analysiszeta potential analysisthin layer chromatography analysiswater content analysisperoxide oxidation and phosphorous content analysischemical stability testingdevelopment of chemical analytical methods in the field of lipidsnutraceuticalsfood productspharmaceutical productsdrug development and commercialization; scientific research and product development and consultation related thereto in the field of pharmaceuticals and chemicals; scientific research services for others; scientific research services for others in the field of lipidsnutraceuticalsfood productspharmaceutical productsdrug development and commercialization; lipidomics servicesidentification and quantification of lipid compounds in a sampleidentification of protein-lipid interactionsidentifying the role of lipids in cellular signaling all in the nature of scientific research; cGMP testing serviceslipid raw material release testingdeveloping of testing specifications and standard operating proceduresquality assurance reviewproduct testingchemical stability testing all in the field of pharmaceuticalslipids and chemicals; formulation servicesdevelopment of standards for liposome and nanoparticle formulationsscaling-up manufacturing processestesting and development of standards for synthesis of lipid compounds for use in formulationsin the field of pharmaceuticalslipidschemicals; providing information relating to chemical characterizationanalysis methodsuses of lipids and related compounds for scientific and medical research purpose
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2025
PUBO
PUBLISHED FOR OPPOSITION
05/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/14/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/17/2025
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
04/11/2025
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
04/11/2025
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
04/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/04/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/14/2025
GNFR
FINAL REFUSAL E-MAILED
02/14/2025
CNFR
FINAL REFUSAL WRITTEN
02/14/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/02/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/29/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/29/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/02/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/07/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/24/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/24/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/24/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/24/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/24/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/21/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/20/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/25/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/04/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/29/2020
GNSL
LETTER OF SUSPENSION E-MAILED
07/29/2020
CNSL
SUSPENSION LETTER WRITTEN
07/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2020
GNRT
NON-FINAL ACTION E-MAILED
01/08/2020
CNRT
NON-FINAL ACTION WRITTEN
01/08/2020
DOCK
ASSIGNED TO EXAMINER
12/30/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2019
NWAP
NEW APPLICATION ENTERED
09/30/2019
Continuous trademark protection
Get notified about every new filing that threatens AVANTI POLAR LIPIDS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.